News
-
Decision C-2987/2021 of 2 September 2024
-
Decision 2C_336/2023 of 25 July 2024
-
Swissmedic Journal 08/2024
-
EMA: Guiding principles for the use of large language models (LLMs) in medicines regulation
-
FOPH: Federal Council reports on strengthening pandemic response and mental health support
-
Swissmedic: Annual Haemovigilance Report 2023
-
Swissmedic: Overview of updates to authorization procedures effective 1 September 2024
-
BGE 150 V 129 (Federal Supreme Court, Decision 9C_135/2022 of 12 December 2023)
-
Swissmedic: Warning regarding allegedly herbal products
-
Decision 2C_422/2022 of 16 January 2024
-
Decision 2C_530/2023 of 23 July 2024
-
FOPH: Switzerland’s new Tobacco Products Ordinance and Act take effect on 1 October 2024
-
FOPH: Transitional funding and legislative updates for the Electronic Patient Record
-
Decision 9C_726/2023 of 16 July 2024
-
Decision 4A_336/2023 of 12 July 2024
-
FOPH: Federal Council adopts measures to enhance supply on medicinal products
-
FOPH: Federal Council extends National Strategy for Non-Communicable Disease Prevention and National Addiction Strategy until 2028
-
FOPH: Ensuring the supply of in-vitro diagnostics and greater transparency for medical devices
-
FOPH: Federal Council adopted new ordinance on the activity of insurance intermediaries
-
Swissmedic: Update on information sheet for non-standardized medicinal products
-
Swissmedic Journal 07/2024